Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate
article
OA: closed
CC0
⤵ 34 in-corpus citations
AI-generated summary
Medroxyprogesterone acetate treatment reduced intraperitoneal inflammation in endometriosis patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
An intraperitoneal inflammatory exudate has been repeatedly observed in infertile women without mechanical compromise of the pelvic viscera, particularly with endometriosis. This is manifested by increases in the peritoneal fluid volume, leukocyte number, and proteolytic enzyme concentrations. We tested the hypothesis that the stimulus responsible for eliciting this intraperitoneal inflammation is retrograde menstruation by measuring the peritoneal fluid volume and leukocyte count in 16 infertile women with endometriosis before and after ovulation suppression with medroxyprogesterone acetate, 30 mg/day for 4 months. Medroxyprogesterone acetate therapy significantly reduced the peritoneal fluid volume (22.5 +/- 4.1 versus 6.8 +/- 0.9 ml mean +/- SE, p less than 0.0001), the peritoneal fluid leukocyte count (30.7 +/- 6.5 versus 7.1 +/- 0.7 x 10(6) cells per patient, p less than 0.0001), and American Fertility Society score (23.2 +/- 5.1 versus 15.4 +/- 4.1, p less than 0.0002). We conclude that medroxyprogesterone acetate treatment reduces the intraperitoneal exudate associated with endometriosis. These results support the contention that the stimulus eliciting the intraperitoneal inflammation in infertile women with endometriosis is retrograde menstruation.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis via openalex
- Cul-de-sac fluid in women with endometriosis: fluid volume, protein and prostanoid concentration during the periovulatory period—days 13 to 18 via openalex
- Cyclic changes of peritoneal fluid parameters in normal and infertile patients. via openalex
- Increased activation of pelvic macrophages in infertile women with mild endometriosis via openalex
- Local peritoneal factors: Their role in infertility associated with endometriosis via openalex
- ORIGIN OF PERITONEAL FLUID IN WOMEN: AN OVARIAN EXUDATION PRODUCT via openalex
- Pelvic macrophages in normal and infertile women: The role of patent tubes via openalex
- Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis via openalex
- Peritoneal Fluid Volume in Endometriosis via openalex
- Peritoneal macrophages and infertility: the association between cell number and pelvic pathology via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Retrograde menstruation in women undergoing chronic peritoneal dialysis. via openalex
- Sperm phagocytosis by human peritoneal macrophages: A possible cause of infertility in endometriosis via openalex
- Sperm survival studies in peritoneal fluid from infertile women with endometriosis and unexplained infertility. via openalex
- W6690236311 via openalex
- W145137148 via openalex
- W343382252 via openalex
- W573615270 via openalex
- W2039144212 via openalex
- W2080201314 via openalex
- W2227993884 via openalex
- W2346704459 via openalex
- W2398575063 via openalex
- W2399672602 via openalex
- W2409510670 via openalex
- W2477008945 via openalex
- W6606484086 via openalex
- W6628680024 via openalex
Cited by (34)
- High intensity interval training is superior to moderate intensity continuous training in enhancing the anti-inflammatory and apoptotic effect of pentoxifylline in the rat model of endometriosis 2023
- Peritoneal inclusion cysts treated with a levonorgestrel-releasing intrauterine system: A case report 2019
- Role of medical therapy in the management of deep rectovaginal endometriosis 2017
- Trauma and endometriosis. A review. May we explain surgical phenotypes and natural history of the disease? 2017
- Endométriose : information aux patientes – il faut arrêter la machine à faire peur ! 2016
- Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment 2016
- Endometriose 2015
- The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety 2015
- Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment 2014
- Aromatase and endometriosis: estrogens play a role 2014
- Endometriosis – Pathogenesis, Diagnosis, and Therapeutic Options for Clinical and Ambulatory Care 2013
- Comparing treatments for endometriosis-related pain symptoms in patients with migraine without aura 2012
- Progestin therapy for endometrial cancer: The potential of fourth-generation progestin (Review) 2012
- Pathophysiology of Infertility in Endometriosis 2011
- Endometriose - Entstehung, Diagnostik, Behandlungsmöglichkeiten und Probleme in Klinik und Praxis 2011
- Expression und Regulation von Enzymen des Östrogenmetabolismus in humanen Endometriumläsionen kultiviert in der Nacktmaus 2007
- The Efficacy, Side-Effects and Continuation Rates in Women With Symptomatic Endometriosis Undergoing Treatment With an Intra-uterine Administered Progestogen (Levonorgestrel): A 3 Year Follow-up 2005
- Advances in the management of endometriosis: an update for clinicians 2005
- Emerging drugs for endometriosis 2004
- Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis 2004
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up 2004
- Progestogens for endometriosis: forward to the past 2003
- Monocyte chemotactic protein-l concentration of in in peritoneal fluid women with endometriosis and its modulation mesothelial cells* 1997
- Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells 1997
- Endometriosis-associated infertility 1997
- Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis 1996
- Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis 1996
- Growth-regulated α expression in the peritoneal environment with endometriosis 1996
- Increased chemotactic activity of peritoneal fluid in patients with endometriosis 1993
- 8 Endometriosis-associated infertility 1993
- Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis 1992
- The pathogenesis and aetiology of endometriosis 1991
- Role of Peritoneal Inflammation in Endometriosis‐associated Infertility 1991
- The stimulus responsible for the peritoneal fluid inflammation observed in infertile women with endometriosis 1991
Source provenance
- europepmc
- last seen: 2026-07-26T06:08:39.051465+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:20.810540+00:00
- unpaywall
- last seen: 2026-07-26T06:48:27.953686+00:00
License: CC0
· commercial use OK